Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,996,200
+$30,401,054 QoQ
Shares Held
730,000
+483.8% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#67
of 1,341 holders
Holding Since
Sep 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$31,640,400
PutShares
660,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $396,101,149 across 12 Drug Manufacturers - General names. NVO ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
100,000 | $119,943,010 | |
| 2 | AMGN |
Amgen Inc
|
281,000 | $101,755,720 | |
| 3 | ABBV |
AbbVie Inc.
|
402,440 | $101,270,001 | |
| 4 | NVO |
Novo Nordisk A S
This page
|
730,000 | $34,996,200 | |
| 5 | BIIB |
Biogen Inc.
|
90,000 | $19,445,400 | |
| 6 | PFE |
Pfizer Inc
|
435,000 | $10,474,800 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,540 | $3,257,834 | |
| 8 | GRFS |
Grifols SA
|
435,361 | $3,082,355 |
All Filings in NVO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,640,400 | 660,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $34,996,200 | 730,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $34,912,500 | 950,000 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $4,595,146 | 125,038 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $26,925,848 | 529,203 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $12,720,000 | 250,000 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $23,649,838 | 426,200 | Put | Sole | 2025-12-15 | |
| 2025-09-30 | $14,128,086 | 254,606 | Shares | Sole | 2025-12-15 | |
| 2025-03-31 | $17,360,000 | 250,000 | Put | Sole | 2025-05-14 | |
| 2024-12-31 | $9,221,344 | 107,200 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $47,311,000 | 550,000 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $55,224,840 | 642,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $14,196,239 | 119,226 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,275,640 | 86,000 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $4,065,585 | 39,300 | Shares | Sole | 2024-02-14 | |
| 2022-12-31 | $3,589,622 | 26,523 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,988,900 | 30,000 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||